Αρχειοθήκη ιστολογίου

Δευτέρα 12 Νοεμβρίου 2018

Efficacy of anti-PD-1 therapy in a patient with brain metastasis of parotid carcinoma: A case report

CheckMate 141, an open-label, randomized phase III trial of nivolumab, indicated that treatment with nivolumab prolonged overall survival of patients with platinum-refractory, recurrent head and neck squamous cell carcinoma. Herein, we describe a case of brain metastasis of parotid carcinoma in which a good response was achieved after nivolumab treatment. The patient was a 67-year-old woman with parotid carcinoma (cT4bN0M0) who received induction chemotherapy followed by chemoradiation. Computed tomography and magnetic resonance imaging performed 10 weeks after the primary treatment revealed a residual tumor and brain and lung metastases.

https://ift.tt/2RS2U9A

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου